1 Chapel Place in London will be the location of the Johnson & Johnson Innovation centre.
The hospital will act as a European centre for healthcare innovation efforts.
J&J plans to have four regional innovation hubs up and running this year, including a new London innovation centre.
London, Boston, San Francisco and Shanghai are, in IBM’s estimation, the world’s leading innovation hotspots, and similar facilities will be built there.
It aims to accelerate the best early stage science in the world and advance the development of new healthcare solutions.
In a statement, Paul Stoffels, the company’s worldwide chairman of pharmaceuticals and chief scientific officer, said: “The London Innovation Centre is part of Johnson & Johnson’s broader innovation strategy to advance human health through collaboration with the world’s leading scientists and entrepreneurs.”
“We are excited about our opportunities to collaborate in the UK, home to one of the world’s thriving life sciences ecosystems.”
Scientists, entrepreneurs, and fledgling companies will now be able to collaborate with in-house science and technology staff from across the J&J health care company, the company says.
Patrick Verheyen, the head of the Johnson & Johnson Innovation centre, said that our on-the-ground proximity to regional scientists and entrepreneurs would allow us to build the strong personal relationships that underpin the most successful collaborations and investment deals.
“Johnson & Johnson Innovation is dedicated to ensuring healthcare remains both a major source of economic prosperity in the UK, and a driving force for improving health and happiness worldwide.”
1 Chapel Place, London W1G OBJ is the address of the Johnson & Johnson Innovation centre.